Golimumab therapy-induced indicators of X-ray inflammation progression and magnitude according to magnetic resonance imaging evidence in patients with rheumatoid arthritis, ankylos...

by Aleksandr Viktorovich Smirnov
Published 2013-06-01

How real is the long-lasting effect of tumor necrosis factor α inhibitors? Focus on immunogenicity

by D.E. Karateev
Published 2014-05-01

The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritis

by S. G. Anikin
Published 2017-03-01

Resolution of the Council of Russian Experts: Apremilast, a phosphodiesterase 4 inhibitor, as a representative of a new class of small molecule compounds: Its place in the treatmen...

by A. A. Kubanov
Published 2017-03-01

The place and value of nonsteroidal anti-inflammatory drugs in the therapy of osteoarthritis

by V. V. Badokin
Published 2016-03-01

Hyaluronic acid preparations in the treatment of osteoarthritis. Synvisk®(Hylan G-F 20): Efficacy and safety

by Natalia Vladimirovna Chichasova
Published 2013-12-01

Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report

by M. N. Starovoitova, O. V. Desinova, N. G. Guseva
Published 2015-03-01

POSSIBILITIES FOR PRESERVING THE RESULTS OF TREATMENT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER DOSE REDUCTION AND/OR DISCONTINUATION OF BIOLOGICAL AGENTS: A REMARCA STUDY

by E. L. Luchikhina, D. E. Karateev, N. V. Demidova, G. S. Gridneva, G. V. Lukina, M. A. Kanonirova, Yu. V. Muravyev, K. A. Kasumova, E. N. Aleksandrova, A. А. Novikov, A. S. Avdeeva
Published 2016-12-01

Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia

by Irina Mikhailovna Marusenko
Published 2013-12-01

On the occasion of the 80th anniversary of Professor A.I. Speransky

by - -
Published 2012-12-01

Prospects for the use of celecoxib in patients with ankylosing spondylitis: impact on retarding disease progression

by Yulia Leonidovna Korsakova
Published 2012-09-01

Rheumatoid arthritis, osteoporosis, possibilities for the correction of bone mineral density

by Rimma Mikhailovna Balabanova
Published 2012-09-01

Osteoarthrosis in outpatient practice

by Elena Andreyevna Galushko, Sh F Erdes, L I Alekseyeva
Published 2012-12-01

Genetically engineered biological agents in therapy for systemic lupus erythematosus

by Elena Aleksandrovna Aseeva, S K Solovyev, E L Nasonov
Published 2013-10-01

Giant cell arteritis. Part III. New trends in its treatment (role of genetically engineered drugs)

by Azamat Makhmudovich Satybaldyev
Published 2013-03-01

Differential diagnosis of monoarthritis

by Alla Aleksandrovna Godzenko
Published 2013-12-01

Comparative pharmacoeconomic analysis of the use of Bonviva® (ibandronat) to prevent fractures in postmenopausal osteoporosis

by E A Pyadushkina, K V Gerasimova, S V Goryainov, Vitaly Vladimirovich Omelyanovsky, M V Avksentyeva, I S Krysanov
Published 2012-12-01

Use of methotrexate in the treatment of psoriasis and psoriatic arthritis

by Tatiana Viktorovna Korotaeva, E L Nasonov, V A Molochkov
Published 2013-06-01

A novel approach to treating osteoarthrosis as a chronic inflammatory disease

by Rimma Mikhailovna Balabanova
Published 2013-06-01

Pain is a major component of quality of life in patients with ankylosing spondylitis and the possibilities of its relief

by Oksana Anatolyevna Pirogova, Т А Raskina, М V Letaeva
Published 2013-10-01